Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study

Conditions: Helicobacter Pylori Infection; Tegoprazan; Furazolidone Interventions: Biological: Tegoprazan-amoxicillin dual therapy Sponsors: Nanjing First Hospital, Nanjing Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials